On 29-11-2019 (Friday), Shares of Adamis Pharmaceuticals Corporation, (NASDAQ: ADMP) displayed a change of -6.02 after which it closed the day’ session at $0.58. The volume amounted to 1116456 shares which compares with the average volume of 1.81M shares. Adamis Pharmaceuticals Corporation, a USA based Company, belongs to Healthcare sector and Drug Delivery industry. The shares of Adamis Pharmaceuticals Corporation was among the active stocks of the last trading sessions.
To clear the blur picture shareholders will need to look a little deeper. The LiveRamp Holdings, Inc. has shown a weekly performance of -45.54% and monthly performance stands at -17.46%.
The stock has shown a quarterly performance of -37.94% and a half-year performance stands at -60.89%. Analyst recommendation for this stock stands at -74.1.
The stock price moved with change of 0.214 to its 50 Day low point and changed -0.5953 comparing to its 50 Day high point.
Looking into the profitability ratios of ADMP stock, the investor will find its ROE, ROA, ROI standing at -90.8%, -69.1% and -79.3%, respectively. The current relative strength index (RSI) reading is 40.15.
Target Price ADMP:
Target Price informs the investors, a stock survey at which a trader is willing to buy or sell a stock. Target pricing at which a trader projects that a buyer will buy a product. Analyst’s mean target price for the company is $3.
The stock price volatility remained at 17.29 in recent month and reaches at 22.38 for the week. The Average True Range (ATR) is also a measure of volatility is currently sitting at 0.16.
Simple Moving Averages ADMP:
The moving average is easy to calculate and once plotted on a chart, is a powerful visual trend-spotting tool. In theory, there is an infinite number of simple moving averages but the most common are three SMA20, SMA50 and SMA200. SMA20 is the last stop on the bus for short-term traders. Its distance from 20-days simple moving average is -33.78% and its distance from 50-days simple moving average is -22.17% while it has a distance of -59.84% from the 200-days simple moving average.
Most Important details of Adamis Pharmaceuticals Corporation (EPS):
EPS in next five year years is expected to touch 2.1% while EPS growth in past 5 year was 2.1% along with sales growth of % in the last five years. EPS growth in next year is estimated to reach -75.4% while EPS growth estimate for this year is set at -75.4%.